Sign in
4/A

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052517

CFO/COO acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Stelmakh Edward CFO/COO 2024-02-15 Grant or award +0 33,365 D
Loading xslF345X05/wk-form4a_1735335531.xml…